ANALYSIS AND SPREAD OF GYRA GENE MUTATIONS ENCODING DRUG RESISTANCE TO FLUOROQUINOLONES IN M. TUBERCULOSIS
- 作者: SALINA T.Y.1, MOROZOVA T.I.1,2
-
隶属关系:
- Razumovsky Saratov State Medical University, Ministry of Health of Russia
- Saratov Regional Clinical Tuberculosis Dispensary
- 期: 编号 6 (2013)
- 页面: 72-74
- 栏目: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/277272
- ID: 277272
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
To investigate the spectrum and spread of gyrA gene mutations, 69 sputum samples from patients with active pulmonary tuberculosis were examined using biological microchips (BIOCHIP-IMB, Moscow). M. tuberculosis DNA was isolated in 60 (86.9%) people. gyrA gene mutations were found in 12 (20%) patients; the mutations were established in codons 88, 90, 91, and 94. Six (50%) showed a combination of two or more mutations. Twenty-nine (48.3%) persons had a codon 95 mutation that was caused by natural gene polymorphism and failed to result in resistance. Thus, the patients living in the Saratov Region are recorded to have a high level of gyrA gene mutations encoding drug resistance to fluoroquinolones.
全文:
作者简介
Tatyana SALINA
Razumovsky Saratov State Medical University, Ministry of Health of Russia
Email: SalinaTU@rambler.ru
T. MOROZOVA
Razumovsky Saratov State Medical University, Ministry of Health of Russia; Saratov Regional Clinical Tuberculosis Dispensary
Email: dispans@san.ru
参考
- Борисов С.Е., Мохирева Л.В., Иванушкина Т.И., Литвинова Н.В. Фторхинолоны в лечении туберкулеза - в поисках новой парадигмы (обзор зарубежной литературы). Туберкулез и болезни легких 2013; 11: 5-16.
- Hooper D.C., Wolfson J.S. The fluoroquinolines: pharmacology, clinical uses, and toxicities in humans. Antimicrob. Agents Chemother. 1985; 28: 716-721.
- Tsukamura M. In vitro antituberculosis activity of a new antibacterial substance ofloxacin (DL8280). Am. Rev. Respir. Dis. 1985; 131: 348-351.
- Truffot-Pernot C., Ji B., Grosset J. Activities of pefloxacin and ofloxacin against mycobacteria in vitro and mouse experiments. Tubercle 1991; 72: 57-64.
- Morozova T.I., Salina T.Yu. Molecular characterization of strains of M. tuberculosis, are resistant to fluoroquinolones, which circulate in the territory of the Saratov region. Eur. Respir. J. 2012; 40(Suppl. 56): 2646
- Takiff N.E. Cloning and nucleotide seguence of M. tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother. 1994; 38: 773-780.
- Титов Л.П., Сетаре М., Суркова Л.К. Характеристика лекарственной устойчивости M. tuberculosis, выделенных от больных туберкулезом и молекулярные характеристики мутаций в гене gyrA. Медицинские новости 2009; 12: 64-66.
- Степашин Ю.Г., Степашина В.Н., Шемякин И.Г. Молекулярные механизмы устойчивости Mycobacterium tuberculosis к лекарственным препапратам. Антибиотики и химиопрепараты 1999; 44(4): 39-43.
- Tokuea Y., Sugano K., Nodaa T. et al. DNA gyrase gyrA gene mutations in ofloxacin-resistant Staphylococcus aureus. International Journal of Аntimicrobial Аgents 1995; 6: 123126.
- Грядунов Д.А., Лапа С.А., Соболев А.Ю. и др. Разработка диагностических систем на основе биологических микрочипов для идентификации и определения чувствительности возбудителя туберкулеза - M. tuberculosis. Научные труды к 75-летию ведущего противотуберкулёзного учреждения г. Москвы. М., 2001: 233-236.
- Сетаре М. Молекулярно-генетическая характеристика лекарственно-резистентных штаммов M. tuberculosis, выделенных от больных туберкулезом. Автореф. дис.. канд. биол. наук. Минск, 2009.
- Zhao B.Y., Pine R., Domagala J., Drlika K. Fluoroguinolone action againts clinical isolates of Mycobacterium tuberculosis: effects of a C-8 metoxyl group on survival in liguid media and in human macrophages. Antimicrob. Agents Chemother. 1999; 43: 661-666.
补充文件
